Search

everythinglearnresearchcommunity

for

Search:↓

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

AMP-303 safely increases hair growth in men with hair loss.

Lidocaine-loaded microparticles effectively relieve pain and fight bacteria in wounds.

Mechanical stress causes ligament thickening through WISP-1 and Hedgehog signaling.

Low-level laser therapy, now called photobiomodulation, is recognized for its broad medical applications and scientific backing.

Juläine injections safely improve hair regrowth in men and women with pattern hair loss.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

A new compound shows promise as a topical treatment for hair loss.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Injectable platelet-rich fibrin can safely and effectively treat melasma.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Low-level laser therapy reduces orthodontic relapse in rats, but fulvic acids do not.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Adding a second method to PROTACs could improve cancer treatment.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.